Surrobody™ BiSpecifics and Drug Conjugation:
The invariant nature of the Surrobody™ SLC allows for efficient assembly, production and purification of bispecific molecules enabling researchers to perform rapid biological assessment. We can readily produce multi-milligram quantities of mammalian protein in as little as five weeks from the discovery of a "hit."
The SLC also procides and ideal scaffold for drug conjugation because ALL Surrobodies use the exact same SLC and therefore, one solution works across the entire platform from monospecific to bispecific agents. We have developed a robust system for conjugation that provides reproducible results across all Surrobodies.
Return to Surrobody Technology
print page